2015
DOI: 10.1002/9781119190134.ch17
|View full text |Cite
|
Sign up to set email alerts
|

Dextran Coated Cerium Oxide Nanoparticles for Inhibiting Bone Cancer Cell Functions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 22 publications
0
4
0
Order By: Relevance
“…They were not toxic to the cell lines T98G (from a human glioblastoma multiform tumor) but caused cell death to BEAS-2B cell line (Park et al, 2008) and human bronchoalveolar carcinoma derived cell line (A549) (Lin et al, 2006) by an apoptotic process, mainly by increasing the levels of ROS and decreasing the levels of GSH and α-tocopherol. In the study of Alpaslan et al (2015), the dextran-coated nanoceria killed much more effectively the osteosarcoma cell line MG-63 (ATCC CRL-1427) than the osteoblast noncancerous cell line (PromoCell, C-12720), suggesting that nanoceria can promisingly be used for treating bone cancer without the appearance of adverse effects to healthy bone cells. CeO 2 NPs showed a rapid uptake from human keratinocyte cells (HaCaT) and co-localized with mitochondria, lysosomes, endoplasmic reticulum, cytoplasm, and nucleus, suggesting that they act as cellular antioxidants in multiple compartments (Singh et al, 2010).…”
Section: Cytotoxicity Of Rare Earth Elementsmentioning
confidence: 99%
“…They were not toxic to the cell lines T98G (from a human glioblastoma multiform tumor) but caused cell death to BEAS-2B cell line (Park et al, 2008) and human bronchoalveolar carcinoma derived cell line (A549) (Lin et al, 2006) by an apoptotic process, mainly by increasing the levels of ROS and decreasing the levels of GSH and α-tocopherol. In the study of Alpaslan et al (2015), the dextran-coated nanoceria killed much more effectively the osteosarcoma cell line MG-63 (ATCC CRL-1427) than the osteoblast noncancerous cell line (PromoCell, C-12720), suggesting that nanoceria can promisingly be used for treating bone cancer without the appearance of adverse effects to healthy bone cells. CeO 2 NPs showed a rapid uptake from human keratinocyte cells (HaCaT) and co-localized with mitochondria, lysosomes, endoplasmic reticulum, cytoplasm, and nucleus, suggesting that they act as cellular antioxidants in multiple compartments (Singh et al, 2010).…”
Section: Cytotoxicity Of Rare Earth Elementsmentioning
confidence: 99%
“…86 For example, in Colorectal Carcinoma Cells, CeO 2 -NPs can induce DNA fragmentation by increasing the production of ROS, resulting in cellular apoptosis through the p53-dependent mitochondrial signaling pathway. 84 Yazici et al 87,88 discovered positive effects to varying degrees on osteosarcoma when they studied the cytotoxicity of 0.1 M and 0.01 M dextrancoated CeO 2 -NPs based on dose and time dependence. After that, the results found that at pH 6.0, CeO 2 -NPs were the most damaging to bone cancer cells and the least damaging to healthy bone cells.…”
Section: Osteosarcomamentioning
confidence: 99%
“…CNPs have shown to scavenge the reactive oxygen species (ROS) and have shown its promise to cure several oxidative stress related disorders [5]. CNPs have also shown their inhibitory effect on cancer progression being toxic to tumor cells and nontoxic to stromal cells and were investigated as a potential nanomedicine for cancer treatment [6][7][8]. Optimal therapeutic performance of these nanoparticles needs a well and stable biological dispersion throughout the duration of treatment and remains a major obstacle in its application [5][6][7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…The sedimentation goes faster with increasing of the nanoparticle concentration. In order to overcome these drawbacks, synthesis of biocompatible CNPs in pure water, citrate, cyclodextrin, polymers and surface modification using few functionalizing moieties such as polyethylene glycol and heparin have already been reported [7,[12][13][14]. Most of those protecting agents were found to be either readily washed off or reduce the catalytic activity of the nanoparticles upon exposure to physiological condition and ended up with short circulation time in in vivo environment [9,15].…”
Section: Introductionmentioning
confidence: 99%